Literature DB >> 9149542

Where is the locus in opioid withdrawal?

M J Christie1, J T Williams, P B Osborne, C E Bellchambers.   

Abstract

Identification of neuroadaptations in specific brain regions that generate withdrawal is crucial for understanding and perhaps treating opioid dependence. It has been widely proposed that the locus coeruleus (LC) is the nucleus that plays the primary causal role in the expression of the opioid withdrawal syndrome. MacDonald Christie, John Williams, Peregrine Osborne and Clare Bellchambers believe that this view and the interpretation of the literature on which it is based are at best controversial. Here, they suggest an alternative view in which regions close to the LC such as the periaqueductal grey, as well as other brain structures which are independent of the LC noradrenergic system, play a more important role in the expression of the opioid withdrawal syndrome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9149542     DOI: 10.1016/s0165-6147(97)01045-6

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  33 in total

1.  Morphine-6 beta-glucuronide has a higher efficacy than morphine as a mu-opioid receptor agonist in the rat locus coeruleus.

Authors:  P B Osborne; B Chieng; M J Christie
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 2.  Imaging chronic daily headache.

Authors:  Sheena K Aurora
Journal:  Curr Pain Headache Rep       Date:  2003-06

3.  CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence.

Authors:  S B Lane-Ladd; J Pineda; V A Boundy; T Pfeuffer; J Krupinski; G K Aghajanian; E J Nestler
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

4.  Gi/o-coupled receptors compete for signaling to adenylyl cyclase in SH-SY5Y cells and reduce opioid-mediated cAMP overshoot.

Authors:  Erica S Levitt; Lauren C Purington; John R Traynor
Journal:  Mol Pharmacol       Date:  2010-11-22       Impact factor: 4.436

5.  Brain norepinephrine rediscovered in addiction research.

Authors:  Gary Aston-Jones; Peter W Kalivas
Journal:  Biol Psychiatry       Date:  2008-06-01       Impact factor: 13.382

Review 6.  Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction.

Authors:  M J Christie
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

7.  Increased opioid inhibition of GABA release in nucleus accumbens during morphine withdrawal.

Authors:  B Chieng; J T Williams
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

Review 8.  The role of the central noradrenergic system in behavioral inhibition.

Authors:  Eric A Stone; Yan Lin; Yasmeen Sarfraz; David Quartermain
Journal:  Brain Res Rev       Date:  2011-03-05

9.  Extracellular signal-regulated kinase (ERK) inhibition does not prevent the development or expression of tolerance to and dependence on morphine in the mouse.

Authors:  Lionel Moulédous; Miguel F Díaz; Howard B Gutstein
Journal:  Pharmacol Biochem Behav       Date:  2007-07-18       Impact factor: 3.533

Review 10.  Reward processing by the opioid system in the brain.

Authors:  Julie Le Merrer; Jérôme A J Becker; Katia Befort; Brigitte L Kieffer
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.